Saranas, a medical device company with a new technology for real-time detection and monitoring of internal bleeding during endovascular procedures, today announced the company was named as one of the Top 4 Innovators at the International Conference for Innovations in Cardiovascular Systems (ICI) in Tel Aviv, Israel.

Saranas, a medical device company with a new technology for real-time detection and monitoring of internal bleeding during endovascular procedures, has been invited to present at the 29th Transcatheter Cardiovascular Therapeutics (TCT) annual scientific symposium of the Cardiovascular Research Foundation (CRF), Oct. 31, 2017, in Denver, CO. Saranas was chosen to participate in the conference’s Shark Tank Competition.

Saranas, a medical device company with a new technology for real-time detection of internal bleeding during cardiac procedures, today announced the appointment of Dr. Philippe Généreux as its Chief Medical Officer.

Saranas, a medical device company with a new technology for real-time detection of internal bleeding during cardiac procedures, has closed a $4 million Series B round of financing. The funding will be used to advance the company’s Early Bird® Bleed Detection device through final product testing and FDA submission later this year.